Manufacturer profileQuidel Cardiovascular Inc.
TaiwanUnited States15 products registeredFeb 23, 2006 – Oct 01, 2021
VerifiedTFDA · Taiwan Food and Drug Administration registry
15
Total products
14
Product types
14
Active products
Oct 2021
Latest registration
Company details
- Address
- 9975 SUMMERS RIDGE ROAD,SAN DIEGO, CA92121,USA
Regulatory footprint
Search Quidel Cardiovascular Inc. across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRecent registrations
Latest 5 products registered by this manufacturer
QuickProfit Expert Fluorescence Analyzer (Unsterilized)
Class 1
Oct 01, 2021
Quick-Profit Poison Drug Screening Reagent
Class 2
Nov 09, 2020
QuickProfit Expert Fluorescence Analyzer (Unsterilized)
Class 1
Jun 17, 2019
Quidel Triage Total 3 Control
Class 2
Apr 28, 2016
QuickProfit Yazi Heart 3-in-1 test reagent
Class 2
Apr 25, 2016
Most popular products
Products with most registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
Recent registered products
Most recent products (showing top 20)
QuickProfit Expert Fluorescence Analyzer (Unsterilized)
Registered: Oct 01, 2021 • Expires: Oct 31, 2025
- Risk Class
- Class 1
- AR
- BIO-CHECK LABORATORIES LTD.
Quick-Profit Poison Drug Screening Reagent
Registered: Nov 09, 2020 • Expires: Nov 09, 2025
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
QuickProfit Expert Fluorescence Analyzer (Unsterilized)
Registered: Jun 17, 2019 • Expires: Jun 17, 2024
Cancelled
- Risk Class
- Class 1
- AR
- BIO-CHECK LABORATORIES LTD.
Quidel Triage Total 3 Control
Registered: Apr 28, 2016 • Expires: Apr 28, 2026
- Risk Class
- Class 2
- Type
- MD
- AR
- BIO-CHECK LABORATORIES LTD.
QuickProfit Yazi Heart 3-in-1 test reagent
Registered: Apr 25, 2016 • Expires: Apr 25, 2026
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
Synagosin I test reagent
Registered: Apr 19, 2016 • Expires: Apr 19, 2026
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
QuickProfit Heart 2-in-1 Test Reagent
Registered: Apr 19, 2016 • Expires: Apr 19, 2026
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
Quickeli Yazi N-terminal brain natriuretic peptide precursor test reagent
Registered: Jul 23, 2015 • Expires: Jul 23, 2025
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
QuickProfit Jackezi 5 Correction Confirmation Solution
Registered: Feb 04, 2010 • Expires: Feb 04, 2025
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
Quick-Profit Ji Tonjaji Liquid 5
Registered: Jan 05, 2010 • Expires: Jan 05, 2025
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
Quick-Profit Poison Drug Screening
Registered: Mar 14, 2006 • Expires: Mar 14, 2026
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
Quickeli Yazi type B sodium urine peptide test.
Registered: Feb 27, 2006 • Expires: Feb 27, 2026
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
QuickProfit Yazi Heart Test Kit
Registered: Feb 24, 2006 • Expires: Feb 24, 2026
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
Quick-Profit Platyez Fibrin Disintegration Product Analysis Reagent
Registered: Feb 23, 2006 • Expires: Feb 23, 2026
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
Quickeli Ji Shortness of breath comprehensive detection reagent
Registered: Feb 23, 2006 • Expires: Feb 23, 2026
- Risk Class
- Class 2
- AR
- BIO-CHECK LABORATORIES LTD.
About this profile
Explore comprehensive manufacturer profile for Quidel Cardiovascular Inc. based in United States through Pure Global AI's free Taiwan medical device database. This manufacturer has 15 products registered in Taiwan across 14 unique product categories. Their regulatory history spans from Feb 23, 2006 to Oct 01, 2021.
This page provides detailed insights including 5 recent product registrations, 5 most popular products with QuickProfit Expert Fluorescence Analyzer (Unsterilized) having 2 registrations, and 1 authorized representatives including BIO-CHECK LABORATORIES LTD.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.